Examining the main challenges in designing and executing MS clinical trials and proposing mitigation strategies that may help alleviate these burdens.
Olja Tanjga, MD
Advertisement
Articles by Olja Tanjga, MD
Examining the main challenges in designing and executing MS clinical trials and proposing mitigation strategies that may help alleviate these burdens.
Advertisement
Latest Updated Articles
Mitigating Risk in Implementing Multi-Regional Trials in Multiple SclerosisPublished: January 2nd 2018 | Updated:
Mitigating Risk in Implementing Multi-Regional Trials in MSPublished: February 1st 2018 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Decision Inputs in Drug Development—Big Vs. Small Pharma: Is There a Difference?
2
ACT Brief: Adaptive Trial Designs, Wegovy’s MASH Breakthrough, and Lilly’s Expanding Partnerships
3
Rethinking Site Selection and Oversight Amid Complex Protocols
4
Bezuclastinib Plus Sunitinib Achieves Strong PFS Benefit in Phase III PEAK Trial for Imatinib-Resistant GIST
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
